Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.

Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Magaret A, Wald A, Corey L.

Sci Transl Med. 2009 Nov 18;1(7):7ra16. doi: 10.1126/scitranslmed.3000193.

2.

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.

Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L.

N Engl J Med. 2000 Mar 23;342(12):844-50.

3.

Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.

Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A.

JAMA. 2011 Apr 13;305(14):1441-9. doi: 10.1001/jama.2011.420.

4.

Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Johnston C, Zhu J, Jing L, Laing KJ, McClurkan CM, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L.

J Virol. 2014 May;88(9):4921-31. doi: 10.1128/JVI.03285-13. Epub 2014 Feb 19.

5.

Virologic characteristics of subclinical and symptomatic genital herpes infections.

Wald A, Zeh J, Selke S, Ashley RL, Corey L.

N Engl J Med. 1995 Sep 21;333(12):770-5.

6.

Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.

Schiffer JT, Abu-Raddad L, Mark KE, Zhu J, Selke S, Koelle DM, Wald A, Corey L.

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18973-8. doi: 10.1073/pnas.1006614107. Epub 2010 Oct 18.

7.

APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding.

Koelle DM, Magaret A, Warren T, Schellenberg GD, Wald A.

Sex Transm Infect. 2010 Jun;86(3):202-6. doi: 10.1136/sti.2009.039735. Epub 2010 Apr 21.

8.

Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.

Nixon B, Fakioglu E, Stefanidou M, Wang Y, Dutta M, Goldstein H, Herold BC.

J Infect Dis. 2014 Feb 15;209(4):510-22. doi: 10.1093/infdis/jit472. Epub 2013 Aug 29.

9.

Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons.

Dhankani V, Kutz JN, Schiffer JT.

PLoS Comput Biol. 2014 Nov 6;10(11):e1003922. doi: 10.1371/journal.pcbi.1003922. eCollection 2014 Nov.

10.

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L.

JAMA. 1998 Jul 1;280(1):61-6.

PMID:
9660365
11.

Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.

Schiffer JT, Swan DA, Corey L, Wald A.

Antimicrob Agents Chemother. 2013 Dec;57(12):5820-9. doi: 10.1128/AAC.01114-13. Epub 2013 Sep 9.

12.

Genital shedding of herpes simplex virus among men.

Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L.

J Infect Dis. 2002 Oct 15;186 Suppl 1:S34-9.

13.

Herpes simplex virus: the importance of asymptomatic shedding.

Koelle DM, Wald A.

J Antimicrob Chemother. 2000 Apr;45 Suppl T3:1-8. Review.

14.

Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.

Crespi CM, Cumberland WG, Wald A, Corey L, Blower S.

Sex Transm Infect. 2007 Aug;83(5):359-64. Epub 2007 May 2.

15.

The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions.

Schiffer JT, Wald A, Selke S, Corey L, Magaret A.

J Infect Dis. 2011 Aug 15;204(4):554-61. doi: 10.1093/infdis/jir314.

16.

Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization.

Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, Hillier SL.

Clin Infect Dis. 2005 May 15;40(10):1422-8. Epub 2005 Mar 29.

17.

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.

Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J.

J Clin Invest. 1997 Mar 1;99(5):1092-7.

18.

A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.

Cowan FM, Pascoe SJ, Barlow KL, Langhaug LF, Jaffar S, Hargrove JW, Robinson NJ, Bassett MT, Wilson D, Brown DW, Hayes RJ.

Sex Transm Infect. 2008 Dec;84(7):548-53. doi: 10.1136/sti.2008.031153. Epub 2008 Aug 6.

PMID:
18684855
19.

Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?

Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ.

Antiviral Res. 2004 Aug;63 Suppl 1:S3-9. Review.

PMID:
15450380
20.

The effects of daily distress and personality on genital HSV shedding and lesions in a randomized, double-blind, placebo-controlled, crossover trial of acyclovir in HSV-2 seropositive women.

Strachan E, Saracino M, Selke S, Magaret A, Buchwald D, Wald A.

Brain Behav Immun. 2011 Oct;25(7):1475-81. doi: 10.1016/j.bbi.2011.06.003. Epub 2011 Jun 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk